Dr Rasha Abdelsalam Elshenawy is a Senior Lecturer and international expert in Antimicrobial Stewardship at the University of Hertfordshire, leading research that directly informs global health policy across 55+ countries.

As Consultant in Antimicrobial Resistance (AMR) and Stewardship (AMS) for the South Centre, Geneva, she develops policy frameworks reaching United Nations member states and collaborates with the World Health Organisation  on antimicrobial stewardship implementation. Her GUIDE Framework for Evidence-Based Antibiotic Prescribing is being adopted across multiple countries through WHO partnerships.

With over 150 peer-reviewed publications and 22+ years of clinical and 
research expertise, she serves as Associate Editor for JAC-Antimicrobial Resistance and has provided written evidence to the UK Parliament Science, Innovation and Technology Committee on antimicrobial resistance policy.

Her research portfolio encompasses systematic reviews, implementation science, digital health innovation, and health systems strengthening across low- and middle-income countries (LMICs). She holds a PhD in Antimicrobial Stewardship and is American Board-certified in pharmacotherapy with infectious diseases specialisation.

Dr Elshenawy's work directly contributes to UN Sustainable Development Goals and global efforts to combat antimicrobial resistance, translating academic research into actionable policy for international health organisations and national health systems.

Her portfolio encompasses over 150 peer-reviewed and non peer-reviewed research outputs, including first-author papers in high-impact journals such as Frontiers in Microbiology, systematic reviews targeting PMC, JAC Antimicrobial Resistance, and policy briefs for international organisations.

Full publication list: 

Google Scholar Profile

ResearchGate

Antimicrobial Stewardship and Resistance

• Evidence-based AMS program development with nearly 25 years of research experience
• Digital health solutions for real-time antimicrobial prescribing support (AMS framework and dashboard)
• Technology evaluation for optimising antibiotic prescribing practices
• Antimicrobial stewardship implementation

Clinical and Hospital Pharmacy Practice

• Medicine safety protocols and adverse event prevention
• Medicine optimization strategies in acute care settings
• Clinical pharmacy integration in multidisciplinary healthcare teams
• Prescribing pattern analysis and intervention effectiveness

Public Health and Global Health Initiatives

• Patient and public engagement in antimicrobial resistance prevention
• Community-based intervention strategies for infection control
• Cross-border AMR transmission patterns and prevention
• Health systems strengthening in diverse healthcare environments

Patient Safety and Quality Improvement

• Healthcare quality improvement methodologies and implementation
• Patient safety frameworks and outcome measurement
• Healthcare professional education and behavior change interventions

Policy Development and Emergency Preparedness

• Healthcare system adaptability during crisis situations
• Emergency preparedness in antimicrobial management and infection control
• Policy framework development for AMR containment
• Pandemic response protocols and health system resilience

Medicine, AI and Digital Health Innovation

• Artificial intelligence (AI) applications in clinical decision-making and prescribing optimization
• AI-enhanced antimicrobial stewardship tools and predictive modeling
• Dashboard development for real-time AMR monitoring
• Health informatics solutions and technology integration in healthcare settings

Antimicrobial Stewardship and Resistance

• GUIDE Framework for Evidence-Based Antibiotic Prescribing: Five-step clinical decision-support model for antimicrobial stewardship across healthcare systems (2025)
• Evidence-based AMS program development and implementation with 22+ years of research and clinical experience spanning 55+ countries.
• Digital health solutions for real-time antimicrobial prescribing support including SMART-AMS dashboard development for acute care settings
• WHO AWaRe (Access, Watch, Reserve) classification implementation and policy translation for national antimicrobial stewardship programmes
• Technology evaluation and optimization of antibiotic prescribing practices in acute care, primary care, and resource-limited settings.
• Cross-national comparative studies of antimicrobial stewardship implementation barriers and facilitators across diverse health systems.
• Policy framework development for antimicrobial resistance containment aligned with WHO Global Action Plan and UN Sustainable Development Goals

Global Health Policy and Implementation Science

• International policy development and consultation for United Nations agencies, South Centre, and WHO AMR Community.
• Health systems strengthening and antimicrobial stewardship implementation across low- and middle-income countries (LMICs).
• Evidence translation from research to policy: UK Parliament submissions, international policy briefs, and WHO guideline development.
• Implementation research examining barriers and facilitators to antimicrobial stewardship adoption across 55+ countries
• South-South cooperation and knowledge exchange for sustainable antimicrobial stewardship in resource-constrained settings.
• Health equity and intersectional approaches to antimicrobial resistance prevention and control

Digital Health and Artificial Intelligence in Clinical Practice

• Artificial intelligence (AI) applications in antimicrobial prescribing 
    decision-support and clinical optimisation
• AI-enhanced antimicrobial stewardship tools including predictive modeling for resistance patterns and treatment outcomes
• Real-time antimicrobial resistance monitoring dashboards and data visualisation for clinical and policy decision-making
• Natural language processing applications for antimicrobial stewardship audit automation and prescribing pattern analysis
• Health informatics solutions integrating electronic prescribing systems with antimicrobial stewardship interventions
• Technology evaluation and digital health implementation in diverse healthcare settings from tertiary hospitals to primary care

Dr Elshenawy delivers comprehensive education in antimicrobial stewardship, medication safety, patient counselling, and clinical pharmacy practice across undergraduate and postgraduate levels. She directs the internationally recognised FADIC Antimicrobial Stewardship School and leads specialised postgraduate modules in drug information fellowship and quality improvement in pharmacy practice. Her interdisciplinary teaching extends to health professionals, pharmacists, doctors, and nurses through dedicated antimicrobial stewardship education with integrated public involvement components.

With substantial experience spanning both undergraduate and postgraduate education, Dr Rasha Elshenawy has delivered over 100 lectures while maintaining extensive module leadership responsibilities. Her academic portfolio encompasses contributions to CPD-accredited drug information programmes, active involvement in curriculum design and assessment development, and supervision of final projects and professional certifications. She collaborates with academic colleagues to advance pharmacy education standards and maintains leadership in programme evaluation initiatives.

Core Teaching and Training Expertise

Clinical Therapeutics and Antimicrobial Stewardship

• Antimicrobial therapies and evidence-based prescribing methodologies
• Antimicrobial stewardship implementation and global burden of AMR mitigation
• Drug-resistant and complex infection management strategies
• Medication management and medication therapy management protocols

Evidence-Based Medicine and Research Excellence

• Scientific publication methodology and peer review processes
• Evidence-based medicine applications and systematic review techniques
• AI in academia and digital health research methodologies
• Research methodology, clinical audit, and data analysis frameworks

Patient Safety and Quality Improvement

• Medication safety protocols and adverse event prevention
• Patient counselling and therapeutic communication strategies
• Quality improvement frameworks and healthcare optimization
• Project management in healthcare settings and clinical practice

Professional Practice and Public Health

• Clinical pharmacy practice and person-centered care delivery
• Public health interventions and population health strategies
• Healthcare professional development and continuing education
• Interprofessional collaboration and team-based care approaches

Professional Consultation and Advisory Services

• Strategic consultation for international health organizations including South Centre and WHO AMR Community
• Expert advisory roles for pharmaceutical companies and healthcare technology developers
• Policy consultation for governmental bodies on antimicrobial resistance containment strategies
• Healthcare system optimization consultation for NHS Foundation Trusts and private healthcare providers

Academic and Editorial Leadership

• Associate Editor responsibilities for JAC-Antimicrobial Resistance journal
• External examination services for postgraduate pharmacy and medical programmes across UK institutions
• Peer review expertise for premier academic journals in clinical pharmacy and infectious diseases
• Academic quality assurance and programme accreditation evaluation services

Conference Speaking and Thought Leadership

• Keynote presentations at international conferences including RPS, BSAC, ACCP, and ECCMID
• Expert panel participation and symposium moderation on antimicrobial stewardship topics
• Professional development workshop delivery for healthcare organizations
• International speaking engagements on global AMR policy and implementation

Research Collaboration and Supervision

• Principal and co-investigator roles in multinational antimicrobial resistance research projects
• Doctoral and master's degree supervision in clinical pharmacy and public health
• Collaborative research partnerships with academic institutions and healthcare organizations
• Grant application development and research project management

Public Engagement and Knowledge Translation

• Media commentary and expert analysis on antimicrobial resistance developments and policy
• Community outreach programmes focusing on public health education and infection prevention
• Professional mentorship of 200+ healthcare practitioners through FADIC programmes
• Public health advocacy and evidence-based policy communication initiatives

Recent High-Impact Engagement:

International Policy Influence:

• GUIDE Framework Launch: Webinar series with WHO Antimicrobial Stewardship teams (October-November 2025)
• World Antimicrobial Awareness Week (WAAW) 2024 and 2025: Featured speaker and panel moderator on global antimicrobial stewardship policy
• South Centre Policy Brief: "Lessons from COVID-19: Strengthening Antimicrobial Stewardship Prior to and During the Pandemic" - Informing policy across 55 UN member states (February 2025)

Parliamentary and Governmental Advisory:

• UK Parliament written evidence: "Antimicrobial resistance: addressing the risks" submitted to Science, Innovation and Technology Committee (March 2024)
• Consultation services for national antimicrobial resistance action plan development and implementation monitoring

Media and Thought Leadership:

• Expert commentary on antimicrobial resistance developments for 
    international health organisations and media outlets
• Keynote presentations on GUIDE Framework implementation at international conferences including [list upcoming: ECCMID, BSAC, etc.]
• Regular contributor to antimicrobial stewardship professional networks and online communities reaching 10,000+ healthcare professionals globally